India joined the Global Fund as a donor in 2006, and has contributed a total US$76.5 million to date. The country pledged US$25 million for the Global Fund’s Seventh Replenishment, covering 2023-2025. This is an increase from its previous pledge of US$22 million for the Sixth Replenishment, covering 2020-2022, demonstrating shared commitment toward ending the epidemics of HIV, TB and malaria.

Pledges and contributions

Data updated on: 20 June 2024


Total pledged

US$94.5 million

Total contributed

US$76.5 million

Seventh Replenishment (2023-2025)

Total pledged

US$25 million

Total contributed

US$8 million

Pledges and contributions by replenishment

See India's profile on the Global Fund Data Explorer

India and the Global Fund

The Government of India, with direct support from Prime Minister Narendra Modi, has shown unprecedented momentum to fight infectious diseases – especially tuberculosis – based on an ambitious national strategy committing to end TB by 2025.

India has been one of the largest implementers of Global Fund grants. Since 2003 and as of November 2020, the Global Fund has disbursed more than $2.36 billion in grants to India for programs to fight the three diseases. The Global Fund has allocated $500 million to India for the next allocation period 2020-2022.

Global health is high on India’s international cooperation agenda. The country has a particular interest in fighting infectious diseases; it seeks to contribute in ending TB globally and eliminating malaria in South Asia. The country also has an interest in neglected tropical diseases. India plays a leading role on global health issues in BRICS and the G20.

From one of the largest recipients of multilateral development aid, India is gradually transitioning into the role of aid provider. Demonstrating firm leadership in global health, the Government of India hosted the Global Fund’s Sixth Replenishment Preparatory Meeting in February 2019 – the first time an implementing country hosted a Replenishment milestone.

A key contribution of India is also making available quality and affordable health products – including generic pharmaceuticals, mosquito nets and diagnostic tests – for programs around the world.

The Global Fund has engaged with the Indian private sector and business leaders, including Tata Trusts, to build support to complement and enhance the government’s leadership and take on a key role in expanding programs through additional funding and innovation.